Moreno, Rafael
Clinical trials referenced in this document:
Documents that mention this clinical trial
Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
https://doi.org/10.1136/jitc-2020-001684
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
https://doi.org/10.1136/jitc-2020-001703
Documents that mention this clinical trial
Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
https://doi.org/10.1136/jitc-2020-001684
Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors
https://doi.org/10.1136/neurintsurg-2019-015137
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
https://doi.org/10.1136/jitc-2020-002086
Systemic cellular viroimmunotherapy for canine high-grade gliomas
https://doi.org/10.1136/jitc-2022-005669
E-102 Super-selective intra-arterial treatment of glioblastoma: current state and future directions
https://doi.org/10.1136/jnis-2023-snis.202
Documents that mention this clinical trial
Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
https://doi.org/10.1136/jitc-2020-001684
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
https://doi.org/10.1136/jitc-2020-002086
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
https://doi.org/10.1136/jitc-2022-006624
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer
Ministerio de Economía y Competitividad (Adenonet BIO2015-68990-REDT)
Ministerio de Economía y Competitividad (BIO2017-897554-C2-1-R)
Generalitat de Catalunya (2017SGR449)
Generalitat de Catalunya (Adenonet BIO2015-68990-REDT)